Such an adequate animal model of GNAO1 encephalopathy can only be generated through introduction (e.g. with CRISPR/Cas9) of the exact pathogenic point mutation into one allele of the endogenous GNAO1 locus, keeping the other allele and the expression control mechanisms intact, and observing the resultant dominant phenotypes. Here, GNAO1 is linked to Encephalopathy.